Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RUBRACA
- CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
- A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer
- Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)
- A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes
- Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma
- A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)
- Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives
- A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)
- Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Rucaparib in Nonmetastatic prOstAte With BRCAness
- A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
- Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor
- Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
- Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
- Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib
- A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
- The Drug Rediscovery Protocol (DRUP Trial)
- A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
- ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
- Pharmacokinetic Drug-Drug Interaction Study of Rucaparib
Clinical trials list
click for details